Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 84901 - 84925 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Troglitazone	Approved Withdrawn	EXO1	9156	downregulated	troglitazone results in decreased expression of EXO1 mRNA	1q43	A24633
Troglitazone	Approved Withdrawn	EXOSC2	23404	downregulated	troglitazone results in decreased expression of EXOSC2 mRNA	9q34.12	A24633
Troglitazone	Approved Withdrawn	EZH2	2146	downregulated	troglitazone results in decreased expression of EZH2 mRNA	7q36.1	A24633
Troglitazone	Approved Withdrawn	FABP1	2168	upregulated	troglitazone results in increased expression of FABP1 mRNA	2p11.2	A22275
Troglitazone	Approved Withdrawn	FABP3	2170	downregulated	troglitazone results in decreased expression of FABP3 mRNA	1p35.2	A24653
Troglitazone	Approved Withdrawn	FABP4	2167	upregulated	troglitazone results in increased expression of FABP4 mRNA	8q21.13	A4277 A24653 A21408 A22609
Troglitazone	Approved Withdrawn	FADS2	9415	downregulated	troglitazone results in decreased expression of FADS2 mRNA	11q12.2	A24654
Troglitazone	Approved Withdrawn	FAM83D	81610	downregulated	troglitazone results in decreased expression of FAM83D mRNA	20q11.23	A24633
Troglitazone	Approved Withdrawn	FANCB	2187	downregulated	troglitazone results in decreased expression of FANCB mRNA	Xp22.2	A24633
Troglitazone	Approved Withdrawn	FANCD2	2177	downregulated	troglitazone results in decreased expression of FANCD2 mRNA	3p25.3	A24633
Troglitazone	Approved Withdrawn	FANCG	2189	downregulated	troglitazone results in decreased expression of FANCG mRNA	9p13.3	A24633
Troglitazone	Approved Withdrawn	FANCL	55120	downregulated	troglitazone results in decreased expression of FANCL mRNA	2p16.1	A24633
Troglitazone	Approved Withdrawn	FAS	355	upregulated	troglitazone results in increased expression of FAS mRNA	10q23.31	A20877
Troglitazone	Approved Withdrawn	FASLG	356	upregulated	troglitazone results in increased expression of FASLG mRNA	1q24.3	A24107
Troglitazone	Approved Withdrawn	FASN	2194	upregulated	troglitazone results in increased expression of FASN mRNA	17q25.3	A22275
Troglitazone	Approved Withdrawn	FBN1	2200	upregulated	troglitazone results in increased expression of FBN1 mRNA	15q21.1	A24633
Troglitazone	Approved Withdrawn	FCMR	9214	upregulated	troglitazone results in increased expression of FCMR mRNA	1q32.1	A24633
Troglitazone	Approved Withdrawn	FEN1	2237	downregulated	troglitazone results in decreased expression of FEN1 mRNA	11q12.2	A24633
Troglitazone	Approved Withdrawn	FILIP1L	11259	downregulated	troglitazone results in decreased expression of FILIP1L mRNA	3q12.1	A24636
Troglitazone	Approved Withdrawn	FMNL2	114793	upregulated	troglitazone results in increased expression of FMNL2 mRNA	2q23.3	A24633
Troglitazone	Approved Withdrawn	FMO1	2326	downregulated	troglitazone results in decreased expression of FMO1 mRNA	1q24.3	A24107
Troglitazone	Approved Withdrawn	FMO1	2326	upregulated	troglitazone results in increased expression of FMO1 mRNA	1q24.3	A24107
Troglitazone	Approved Withdrawn	FMO5	2330	downregulated	troglitazone results in decreased expression of FMO5 mRNA	1q21.1	A24107 A22609
Troglitazone	Approved Withdrawn	FN1	2335	downregulated	troglitazone results in decreased expression of FN1 mRNA	2q35	A24117
Troglitazone	Approved Withdrawn	FOS	2353	downregulated	troglitazone results in decreased expression of FOS mRNA	14q24.3	A24633

Displaying entries 84901 - 84925 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability